Privia Health Group (NASDAQ:PRVA) Given New $40.00 Price Target at Piper Sandler

Privia Health Group (NASDAQ:PRVA - Get Free Report) had its price target hoisted by research analysts at Piper Sandler from $25.00 to $40.00 in a note issued to investors on Friday,Benzinga reports. The firm currently has an "overweight" rating on the stock. Piper Sandler's price objective would suggest a potential upside of 56.74% from the company's current price.

A number of other research analysts have also issued reports on PRVA. Needham & Company LLC boosted their price objective on Privia Health Group from $25.00 to $30.00 and gave the company a "buy" rating in a research report on Friday. Macquarie assumed coverage on Privia Health Group in a research note on Monday, December 16th. They issued an "outperform" rating and a $25.00 target price on the stock. Barclays upped their price target on shares of Privia Health Group from $19.00 to $21.00 and gave the stock an "equal weight" rating in a research report on Friday, November 8th. JMP Securities reiterated a "market outperform" rating and issued a $26.00 price objective on shares of Privia Health Group in a research report on Friday, February 14th. Finally, Truist Financial upped their target price on shares of Privia Health Group from $24.00 to $27.00 and gave the stock a "buy" rating in a research report on Friday, November 8th. One investment analyst has rated the stock with a hold rating, thirteen have assigned a buy rating and two have given a strong buy rating to the company's stock. According to data from MarketBeat, Privia Health Group presently has an average rating of "Buy" and an average price target of $26.47.

Remove Ads

Privia Health Group Trading Up 2.2 %

NASDAQ PRVA traded up $0.56 during trading hours on Friday, reaching $25.52. The company's stock had a trading volume of 1,021,318 shares, compared to its average volume of 752,447. The business has a 50-day simple moving average of $22.50 and a 200 day simple moving average of $20.64. Privia Health Group has a 52 week low of $15.92 and a 52 week high of $26.04. The stock has a market cap of $3.06 billion, a PE ratio of 255.23, a PEG ratio of 3.47 and a beta of 0.87.

Institutional Inflows and Outflows

A number of institutional investors have recently bought and sold shares of the company. First Horizon Advisors Inc. increased its holdings in Privia Health Group by 53.8% during the 4th quarter. First Horizon Advisors Inc. now owns 1,807 shares of the company's stock worth $35,000 after purchasing an additional 632 shares in the last quarter. EverSource Wealth Advisors LLC lifted its holdings in Privia Health Group by 7,833.3% during the 4th quarter. EverSource Wealth Advisors LLC now owns 2,380 shares of the company's stock valued at $47,000 after purchasing an additional 2,350 shares during the last quarter. Financial Management Professionals Inc. bought a new stake in shares of Privia Health Group during the 4th quarter worth about $51,000. Quarry LP grew its holdings in Privia Health Group by 344.6% in the 3rd quarter. Quarry LP now owns 3,268 shares of the company's stock valued at $60,000 after buying an additional 2,533 shares in the last quarter. Finally, KBC Group NV increased its position in Privia Health Group by 34.6% during the 3rd quarter. KBC Group NV now owns 3,385 shares of the company's stock worth $62,000 after buying an additional 871 shares during the period. Institutional investors and hedge funds own 94.48% of the company's stock.

About Privia Health Group

Privia Health Group, Inc operates as a national physician-enablement company in the United States. The company collaborates with medical groups, health plans, and health systems to optimize physician practices, enhance patient experiences, and reward doctors for delivering care in-person and virtual settings.